- The BioTech Quality Group joins Assystem S.A.
- ShiftIN Partners sold to Sia Partners
- Livingbridge invests in TSA Management
- Pathway to Your Potential completes strategic alliance with Mercer Australia
Last quarter proved to be a busy one for Equiteq and its clients with consulting deals closing around the world. The following recaps the sale and investment opportunities completed for clients in Q4 2017.
The BioTech Quality Group joins Assystem S.A.
Industry: Life sciences consulting Date: 1 December 2017 Geography: Central Europe
Equiteq facilitated the sale of Life sciences consulting client, The Biotech Quality Group (BQG), to international engineering group, Assystem S.A.
BQG specializes in performance management and regulatory compliance in Europe’s pharmaceutical and biotech industries, and has developed a range of bespoke methods and tools aimed at increasing the maturity and transforming the practices of the (bio)pharmaceutical industry.
The strategic acquisition of BQG significantly moves Assystem forward in the implementation of its Life sciences strategy of becoming a European leader in the areas of commissioning, certification, validation and regulatory compliance in the European pharmaceutical and biotech industries.
The deal is also indicative of the growing volume of life sciences M&A expected to take place in 2018. Recent reports by EY and law firm Baker McKenzie predict a significant increase in deals, with EY estimating 2018 total deal values exceeding $200 billion. According to EY’s report, 60 percent of life sciences executives surveyed in October 2017 plan to actively pursue M&A in the next 12 months, compared with 46 percent in April.
To read our case study on this deal, please click here.